Hubei Guangji Pharmaceutical Co Ltd (000952.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE0000010R5
Price
5.82 CNY
Market cap
2.02 bn CNY
P/E (2025)
–
P/S (2025)
3.23
Dividend yield
0.00 %
Net margin
-64.83 %
Return on equity (ROE)
-61.87 %
Return on assets (ROA)
-17.49 %
Hubei Guangji Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 638.80 m CNY | 623.97 m CNY |
| Gross profit | 114.03 m CNY | 165.80 m CNY |
| Operating income | -317.90 m CNY | -112.08 m CNY |
| EBIT | -257.94 m CNY | -391.95 m CNY |
| Net income | -295.29 m CNY | -404.49 m CNY |
| Diluted EPS – continuing operations | -0.84 CNY | -1.17 CNY |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hubei Guangji Pharmaceutical Co Ltd
Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, pharmaceutical preparations, and feed additives in China and internationally. The company also exports its products. Hubei Guangji Pharmaceutical Co., Ltd. was founded in 1969 and is based in Wuxue, China.
More stocks
- Hanwha Galleria Corp. (452260.KS)
- Princeton Bancorp, Inc. (BPRN)
- Flying Technology Co Ltd (603488.SS)
- Jiangsu Hualv Biological Technology Co.Ltd. (300970.SZ)
- Nanjing Aolian Ae&Ea Co Ltd (300585.SZ)
- Acer E-Enabling Service Business Inc. (6811.TWO)
- AMES NATIONAL CORP (ATLO)
- Kailong High Technology Co. Ltd. (300912.SZ)
- Yangzhou Chenhua New Material Co Ltd (300610.SZ)
- Hanyang Digitech Co. Ltd (078350.KQ)
- Jiangsu Yuxing Film Tech (300305.SZ)
- GRAFTECH INTERNATIONAL LTD (EAF)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.